You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
Turn on more accessible mode
Turn off more accessible mode
Skip Ribbon Commands
Skip to main content
Turn off Animations
Turn on Animations
Sign In
This page location is:
Lab Test Reference Manual
Human Reference Manual
Pages
24762
Lab Test Reference Manual
Human Reference Manual
Currently selected
24762
Congenital Thrombotic Risk Panel
Marshfield Lab Public WebSite
Marshfield Clinic Public WebSite
It looks like your browser does not have JavaScript enabled. Please turn on JavaScript and try again.
Search
Test Code
Laboratory Section
All
Test Category
All
Browse By Test Name
#
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Additional Information
Libraries
Newsletter Document Library
Regional Menus Pages
Lists
Lab Clinical Practice Guidelines
Antimicrobial Susceptibility Panels
Toxicology Information
Urine Preservatives
Requisition Forms and Instructions
Testing
Newsletter Links
Newsletters 2014
Newsletters 2015
Newsletters 2016
Newsletters 2017
Newsletters 2018
Cumulative Antibiogram Reports
testz
Human Test Code IDs
Recent
Newsletters 2025
Newsletters 2024
Newsletters 2023
Newsletters 2022
Antibiogram-PDFs
Site Contents
Congenital Thrombotic Risk Panel
Test Code: CTR
Overview
Ordering
Specimen
Performing
Clinical/Interpretive
Contacts
Coding
Synonyms/Keywords
Synonyms, Keywords
Hypercoagulability, Thrombophilia, PROTSI, PROT-CF, PTG, ATIII, FVL
Test Components
Test Components
Antithrombin III, Functional (ATIII), Protein C Activity (PROT-CF), Free Protein S Antigen, Factor V Leiden Mutation (FVL), Prothrombin Gene Mutation (PTG).
Useful For
Useful For
The congenital thrombotic risk panel is used to identify or rule out congenital deficiencies of natural coagulation inhibitory proteins or mutated procoagulants associated with a high incidence of thrombotic disease.
Specimen Requirements
Specimen Requirements
Specimen Type
Preferred Container/Tube
Acceptable Container/Tube
Specimen Volume
Specimen Minimum Volume
(allows for 1 repeat)
Pediatric Minimum Volume
(no repeat)
Whole Blood
and *Platelet Poor Citrated Plasma
EDTA Lavender Top Tube (LTT) and 3.2% Citrated Blue Top Tube (BTT)
2.0 mL EDTA whole blood and 4.5 mL citrated plasma divided into six 0.75 mL aliquots
1.0 mL EDTA whole blood and 2.25 mL citrated plasma divided into three 0.75 mL aliquots
Collection Processing Instructions
Collection Processing
Citrated Blue Top Tube (BTT) plasma:
- Collect in approximately 2-3 Citrated Blue Top Tubes (BTT).
- Citrate anticoagulant must be adjusted for HCT >55%.
- Tube must be at least 90% full.
- Invert completely 3-4 times (without shaking) to mix.
*See Instructions for:
Prep
aration of Platelet Poor Plasma
Specimen Stability Information
Specimen Stability Information
Specimen Type
Temperature
Time
Whole Blood
Ambient
24 Hours
Refrigerated
<= 15 Days
Frozen
<= 3 Months
Plasma
Frozen (-70)
6 Months
Rejection Criteria
Rejection Criteria
Clotted or Hemolyzed
Contamination with IV or Hickman Line fluids
Specimens that thaw during storage or transport
Performing Laboratory Information
Performing Laboratory Information
Performing Location
Day(s) Test Performed
Analytical Time
Methodology/Instrumentation
Marshfield
ATIII: Monday - Friday
Less than 2 hours
Chromogenic/Siemens CS 2500
PROTCF: Weekly
Less than 2 hours
Chromogenic/ACL TOP 550
PTG: Monday - Friday
6-8 hours
Genetic Mutation
FVL: Monday - Friday
6-8 hours
Genetic Mutation
PROTSI: Tuesday and Friday
2-4 hours
Liatest/IL ACL TOP 550
PROT-CI: Weekly
2-4 hours
Liatest/IL ACL TOP 550
Test Information
Test Information
The panel includes Antithrombin III, Protein C Activity, Free Protein S Antigen, Factor V Leiden Mutation, and Prothrombin Gene Mutation. This panel measures the natural inhibitor proteins, antithrombin, protein C, and protein S. If the protein C activity is reduced a Protein C Antigen (PROT-CI) will be performed. If the free protein S antigen is reduced, protein S activity may be ordered upon pathologist approval. The panel also identifies the mutated procoagulants factor V Leiden and prothrombin 20210A. DNA analysis is performed to identify the mutated form of Factor V and the prothrombin gene mutation. An interpretation of test results is provided.
Reference Range Information
Reference Range Information
Performing Location
Reference Range
Marshfield
See individual test listings for reference ranges.
Outreach CPTs
Outreach CPT Codes
CPT
Modifier
(if needed)
Quantity
Description
Comments
85300
Antithrombin III. Functional
85303
Protein C Activity (Functional)
85306
Protein S Free Antigen
81240
Prothrombin Gene Mutation
85302
Protein C Antigen, Total (if needed)
81241
Factor V Leiden (if needed)
Synonyms/Keywords
Synonyms, Keywords
Hypercoagulability, Thrombophilia, PROTSI, PROT-CF, PTG, ATIII, FVL
Test Components
Test Components
Antithrombin III, Functional (ATIII), Protein C Activity (PROT-CF), Free Protein S Antigen, Factor V Leiden Mutation (FVL), Prothrombin Gene Mutation (PTG).
Ordering Applications
Ordering Applications
Ordering Application
Description
Centricity
Congenital Thrombotic Risk Pnl
Cerner
Congenital Thrombotic Risk Panel
COM
Congenital Thrombotic Risk Panel
If the ordering application you are looking for is not listed, contact your local laboratory for assistance.
Specimen Requirements
Specimen Requirements
Specimen Type
Preferred Container/Tube
Acceptable Container/Tube
Specimen Volume
Specimen Minimum Volume
(allows for 1 repeat)
Pediatric Minimum Volume
(no repeat)
Whole Blood
and *Platelet Poor Citrated Plasma
EDTA Lavender Top Tube (LTT) and 3.2% Citrated Blue Top Tube (BTT)
2.0 mL EDTA whole blood and 4.5 mL citrated plasma divided into six 0.75 mL aliquots
1.0 mL EDTA whole blood and 2.25 mL citrated plasma divided into three 0.75 mL aliquots
Collection Processing
Collection Processing
Citrated Blue Top Tube (BTT) plasma:
- Collect in approximately 2-3 Citrated Blue Top Tubes (BTT).
- Citrate anticoagulant must be adjusted for HCT >55%.
- Tube must be at least 90% full.
- Invert completely 3-4 times (without shaking) to mix.
*See Instructions for:
Prep
aration of Platelet Poor Plasma
Specimen Stability Information
Specimen Stability Information
Specimen Type
Temperature
Time
Whole Blood
Ambient
24 Hours
Refrigerated
<= 15 Days
Frozen
<= 3 Months
Plasma
Frozen (-70)
6 Months
Rejection Criteria
Rejection Criteria
Clotted or Hemolyzed
Contamination with IV or Hickman Line fluids
Specimens that thaw during storage or transport
Useful For
Useful For
The congenital thrombotic risk panel is used to identify or rule out congenital deficiencies of natural coagulation inhibitory proteins or mutated procoagulants associated with a high incidence of thrombotic disease.
Test Components
Test Components
Antithrombin III, Functional (ATIII), Protein C Activity (PROT-CF), Free Protein S Antigen, Factor V Leiden Mutation (FVL), Prothrombin Gene Mutation (PTG).
Reference Range Information
Reference Range Information
Performing Location
Reference Range
Marshfield
See individual test listings for reference ranges.
For more information visit:
http://labtestsonline.org
Performing Laboratory Information
Performing Laboratory Information
Performing Location
Day(s) Test Performed
Analytical Time
Methodology/Instrumentation
Marshfield
ATIII: Monday - Friday
Less than 2 hours
Chromogenic/Siemens CS 2500
PROTCF: Weekly
Less than 2 hours
Chromogenic/ACL TOP 550
PTG: Monday - Friday
6-8 hours
Genetic Mutation
FVL: Monday - Friday
6-8 hours
Genetic Mutation
PROTSI: Tuesday and Friday
2-4 hours
Liatest/IL ACL TOP 550
PROT-CI: Weekly
2-4 hours
Liatest/IL ACL TOP 550
For billing questions, see Contacts
Outreach CPTs
Outreach CPT Codes
CPT
Modifier
(if needed)
Quantity
Description
Comments
85300
Antithrombin III. Functional
85303
Protein C Activity (Functional)
85306
Protein S Free Antigen
81240
Prothrombin Gene Mutation
85302
Protein C Antigen, Total (if needed)
81241
Factor V Leiden (if needed)
Return To Top
For most current information refer to the Marshfield Laboratory online reference manual.